Vor Biopharma Inc. (VOR) Latest Stock News & Headlines
Get the latest Vor Biopharma Inc. (VOR) stock news and headlines to help you in your trading and investing decisions.
Vor Biopharma Inc. (VOR) Stock Price, News, Quote & History
Find the latest Vor Biopharma Inc. (VOR) stock quote, history, news and other vital information to help you with your stock trading and investing.
VOR News Today | Why did Vor Biopharma stock go down today?
Dec 31, 2024 · Shares of Vor Biopharma Inc. (NYSE:VOR - Get Free Report) have been assigned a consensus rating of "Buy" from the six ratings firms that are presently covering the firm, MarketBeat.com reports. Six analysts have rated the stock with a buy rating.
Vor Bio Announces $55.6 Million Private Placement - Yahoo Finance
Dec 27, 2024 · Vor’s trem-cel therapy, which uses CRISPR/cas9 to edit the bone marrow of patients, represents a new potential breakthrough. Early data released by Vor suggest a potent effect, which now must be ...
What's Going On With Vor Biopharma Shares Friday?
Dec 27, 2024 · As part of the PIPE, Vor will issue a total of 55,871,260 shares of common stock and accompanying warrants to purchase an additional 69,839,075 shares, priced at $0.99425 per share and warrants.
Home - VOR News
(VOR News) – President Joe Biden pledged to defend transgender Americans from Republican policies that depicted them as a threat... News 2 days ago. Mike Johnson Faces a Leadership Test When the US House Begin its New Session With a Vote. Politics 2 days ago.
Vor Bio Announces $55.6 Million Private Placement
CAMBRIDGE, Mass., Dec. 27, 2024 (GLOBE NEWSWIRE) -- Vor Bio (Nasdaq: VOR), a clinical-stage cell and genome engineering company, today announced that it has entered into a securities purchase...
Vor Bio announces $55.6M private placement, shares soar
Dec 27, 2024 · Vor Bio (NASDAQ: VOR) shares soared more than 20% in Friday pre-market trading, after it said that it has entered into a securities purchase agreement for a private investment in public equity...
Promising Clinical Outcomes and Strategic Acquisitions Bolster …
Sep 5, 2024 · Vor Bio announces new data, plans to approach FDA on trial design by year-end; New Clinical Data Validates Vor Bio’s Approach of Using Shielded Transplants to Deliver Targeted Therapies
Vor Biopharma Inc. (VOR) Latest Stock News - Seeking Alpha
Dec 19, 2024 · Get the latest news and real-time alerts from Vor Biopharma Inc. (VOR) stock at Seeking Alpha.
- Some results have been removed